about
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic reviewCannabinoids in health and diseaseAlzheimer's disease; taking the edge off with cannabinoids?Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisCannabinoids and Epilepsy.Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.Sativex(®) (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data.Cost-effectiveness of Sativex in multiple sclerosis spasticity: new data and application to Italy.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Cannabinoids in the management of spasticity associated with multiple sclerosis.Managing neuropathic pain with Sativex: a review of its pros and cons.Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityImmunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine.Cannabinoids, multiple sclerosis and neuroprotection.Management of pain in the elderly at the end of life.Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity.Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough?Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain.A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice.Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.Pharmacological Management of Cancer-Related Pain.Cannabinoids in the management of difficult to treat painA drug discovery case history of 'delta-9-tetrahydrocannabinol, cannabidiol'.Multiple sclerosis symptoms and spasticity management: new data.Break-out session highlights.Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
P2860
Q21261356-865408A4-F0D5-4A9E-96B7-BDC07C544202Q24633884-7C5C2C00-AF5D-4D6C-9080-F0348884AC04Q24681412-8E184DEE-1023-4F99-8CBF-914A9B5D6669Q26770823-C1D728F9-F656-4016-8EDF-ACE16DCBA9E6Q27336451-DA9DBF34-A87E-447C-A472-3F1B574B7C66Q31028236-B7B7A155-DCC6-4551-9D88-F452E2B1D58EQ33857586-E1389F0A-08B1-4A9B-BD43-B319BBB6549EQ35577414-8E2E6A65-6158-4035-8069-F667D3E82349Q35613040-E71D1F06-BB50-498B-B92F-8389586749B5Q37062594-7210CEB2-F056-4D76-9E48-32D525D78111Q37142074-74D5C0EB-5125-4234-BCBE-F9BB95C0F5E7Q37235845-479A1F0E-6693-4AF8-8617-163C22F626A6Q37244823-5DB70BDC-1F71-419D-9451-039151CF62D9Q37860314-87BB9CD0-0A17-42C8-AA14-1A1A0DB68942Q37871980-AD13858C-3FE6-48FB-B342-5A6E375AFE41Q37960199-875C14A0-F2C6-4486-AED7-FE23D0594BB2Q37998511-61134E43-6BA0-490A-9050-7476C0DA245DQ38003185-82935AF5-8E59-48F0-9F43-7FB7D1097497Q38003186-E771A371-1308-4EFA-BCA3-A65D512FB492Q38078053-90AD9376-7865-44E9-80DC-2947F490D1A0Q38078054-AD7DAB30-43D8-4C3F-ADC0-21A6422D8A92Q38167397-6AC5B252-9D69-4F8D-AC98-0F5916CC94E6Q38208999-987EA633-F464-4850-AA77-EE096D000E7EQ38672359-F16A4A84-FE93-4602-9917-29CBD2570D44Q41687142-80336134-C1CD-42D7-AF15-7215DEDE6E86Q44830885-5578B669-635B-4605-A2B3-E0248F1B0FCEQ47588014-12E22AB3-14F0-4702-B283-7403BD1699E8Q49972450-ED2096DD-DAA1-4F92-BC9C-C984E6106469Q52150999-4398DE82-432E-4BB6-A104-451B21DAC98A
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Combined cannabinoid therapy via an oromucosal spray.
@ast
Combined cannabinoid therapy via an oromucosal spray.
@en
type
label
Combined cannabinoid therapy via an oromucosal spray.
@ast
Combined cannabinoid therapy via an oromucosal spray.
@en
prefLabel
Combined cannabinoid therapy via an oromucosal spray.
@ast
Combined cannabinoid therapy via an oromucosal spray.
@en
P1433
P1476
Combined cannabinoid therapy via an oromucosal spray.
@en
P2093
Jordi Perez
P304
P356
10.1358/DOT.2006.42.8.1021517
P577
2006-08-01T00:00:00Z